These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 236395)

  • 1. Transplantation behavior of allotransplantable tumor lines derived from immunologically modified hosts.
    Parks RC; Jacobs BB
    J Natl Cancer Inst; 1975 May; 54(5):1079-83. PubMed ID: 236395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor acceptance modified by passage in hybrids with graft-versus-host reaction.
    Jacobs BB; Parks RC
    Exp Hematol; 1978 Nov; 6(10):785-90. PubMed ID: 33818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of donor immunocompetent cells in allograft rejection.
    Jacobs BB; Leonard L; Parks RC
    J Natl Cancer Inst; 1976 Aug; 57(2):345-8. PubMed ID: 1003516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered host-allograft relationships for mouse tumors modified by prior passage in vitro and in vivo. II. Reactivity of lymphoid cells.
    Jacobs BB
    J Natl Cancer Inst; 1972 Oct; 49(4):1085-91. PubMed ID: 4404346
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.
    Prager MD; Baechtel FS; Ribble RJ; Ludden CM; Mehta JM
    Cancer Res; 1974 Dec; 34(12):3203-9. PubMed ID: 4429949
    [No Abstract]   [Full Text] [Related]  

  • 6. Antigenic changes of DBA/2J mastocytoma cells when grown in the BALB/c mouse.
    Wolf JE; Faanes RB; Choi YS
    J Natl Cancer Inst; 1977 May; 58(5):1407-12. PubMed ID: 67213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attempted induction of tumor antigens in carcinogen-treated cells.
    Outzen HC; Andrews EJ; Basombrío MA; Litwin S; Prehn RT
    J Natl Cancer Inst; 1972 Nov; 49(5):1295-302. PubMed ID: 4568086
    [No Abstract]   [Full Text] [Related]  

  • 8. Increase in immunogenicity of a pulmonary squamous-cell carcinoma, propagated in vitro.
    Jamasbi RJ; Nettesheim P
    Int J Cancer; 1977 Dec; 20(6):817-23. PubMed ID: 591125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the immune response to transplantation antigens. III. Further studies on the effects of Freund's complete adjuvant on the immune response of mice to allogeneic tumour antigen.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):469-79. PubMed ID: 4157121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.
    Röllinghoff M; Rouse BT; Warner NL
    J Natl Cancer Inst; 1973 Jan; 50(1):159-72. PubMed ID: 4571237
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytotoxic lymphocytes and anti-tumor immunity].
    Cerottini JC; Brunner KT
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):659-68. PubMed ID: 4403239
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor-associated transplantation antigens of myelomas induced in BALB-c mice.
    Williams WH; Krueger RG
    J Natl Cancer Inst; 1972 Dec; 49(6):1613-20. PubMed ID: 4119165
    [No Abstract]   [Full Text] [Related]  

  • 13. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
    [No Abstract]   [Full Text] [Related]  

  • 14. Spleen cell transplantation in mice: influence of non-H-2 M locus on graft-vs.-host and host-vs.-graft reactions.
    Huber B; Peña-Martinez J; Festenstein H
    Transplant Proc; 1973 Dec; 5(4):1373-5. PubMed ID: 4149546
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune inhibition of allogeneic lymphoma cells in the peritoneal cavity of mice.
    Fioretti MC; Libarati M; Bonmassar E; Cudkowicz G
    Cancer Res; 1975 Jan; 35(1):30-6. PubMed ID: 1089042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphomas in mice: failure of induction after a graft-versus-host reaction.
    Rossi GB; Friend C
    Science; 1970 Mar; 167(3923):1383-5. PubMed ID: 4391710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
    Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S
    J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered allotransplantability of BALB/c Leydig cell tumor after organ culture or cell suspension.
    Ninnemann JL; Good RA
    Transplantation; 1975 Jan; 19(1):42-7. PubMed ID: 804191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of tumors as a result of graft-versus-host reaction.
    Cornelius EA
    Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid viral induction of murine lymphomas in the graft-versus-host reaction.
    Cornelius EA
    J Exp Med; 1972 Dec; 136(6):1533-44. PubMed ID: 4404880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.